Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.2B
Gross Profit 253.4M 21.71%
Operating Income 67.5M 5.78%
Net Income 54.3M 4.66%

Balance Sheet Metrics

Total Assets 607.1M
Total Liabilities 185.0M
Shareholders Equity 422.1M
Debt to Equity 0.44

Cash Flow Metrics

Operating Cash Flow 135.5M
Free Cash Flow 173.7M

Revenue & Profitability Trend

Progyny Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue1.2B1.1B786.9M500.6M344.9M
Cost of Goods Sold913.9M849.8M619.6M388.5M274.8M
Gross Profit253.4M238.8M167.3M112.1M70.1M
Operating Expenses185.9M176.6M144.0M79.8M61.7M
Operating Income67.5M62.2M23.3M32.3M8.3M
Pre-tax Income83.2M70.7M24.4M32.4M8.7M
Income Tax28.9M8.7M-5.9M-33.3M-37.8M
Net Income54.3M62.0M30.4M65.8M46.5M
EPS (Diluted)-$0.62$0.30$0.66$0.47

Income Statement Trend

Progyny Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets472.7M640.4M433.9M258.5M190.2M
Non-Current Assets134.4M116.2M109.1M99.5M63.7M
Total Assets607.1M756.6M543.0M358.1M253.9M
Liabilities
Current Liabilities168.6M186.0M159.5M98.8M77.8M
Non-Current Liabilities16.4M17.2M6.5M7.4M9.2M
Total Liabilities185.0M203.2M166.0M106.2M87.0M
Equity
Total Shareholders Equity422.1M553.4M377.0M251.8M166.9M

Balance Sheet Composition

Progyny Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income54.3M62.0M30.4M65.8M46.5M
Operating Cash Flow135.5M185.8M53.4M13.4M13.6M
Investing Activities
Capital Expenditures-5.4M-3.6M-3.2M-2.1M-1.0M
Investing Cash Flow195.8M-200.5M-43.9M8.8M-40.0M
Financing Activities
Dividends Paid-----
Financing Cash Flow-312.3M-17.2M-12.1M-18.0M-9.8M
Free Cash Flow173.7M185.2M77.2M23.9M35.2M

Cash Flow Trend

Progyny Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 36.47
Forward P/E 27.36
Price to Book 3.78
Price to Sales 1.47
PEG Ratio 27.36

Profitability Ratios

Profit Margin 4.33%
Operating Margin 7.46%
Return on Equity 10.11%
Return on Assets 5.99%

Financial Health

Current Ratio 2.39
Debt to Equity 6.19
Beta 1.32

Per Share Data

EPS (TTM) $0.57
Book Value per Share $5.49
Revenue per Share $13.67

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
pgny1.8B36.473.7810.11%4.33%6.19
UnitedHealth 277.2B12.792.9322.70%5.39%77.28
Elevance Health 84.1B14.501.9814.18%3.23%70.40
Clover Health 1.4B-34.694.27-7.75%-1.69%0.00
Cigna 84.7B17.662.1313.21%1.97%75.34
CVS Health 84.5B15.951.106.93%1.40%105.32

Financial data is updated regularly. All figures are in the company's reporting currency.